SCHEMBL18830184

SCHEMBL18830184

COc1ccc(Nc2nc(Cl)ncc2N=N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ AURKA O14965 2/20 0.46
▸ SYK P43405 1/20 0.46
▸ PDPK1 O15530 1/20 0.44
▸ PIK3CA P42336 1/20 0.42
▸ PIK3CB P42338 1/20 0.42
▸ PIK3CG P48736 1/20 0.42
▸ GAA P10253 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ NR4A1 P22736 1/20 0.41
▸ CDK5 Q00535 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18830586 0.87 KDM4E (0.53) MAPTSYKRAB9ANPC1KDM4E
SCHEMBL18830446 0.82 CCNT1 (0.40) AURKASYKGAAMEN1KMT2A
SCHEMBL29019893 0.81 MAPT (0.55) MAPTSMN1; SMN2AURKASYKPDPK1
SCHEMBL30394922 0.81 MAPT (0.55) MAPTSMN1; SMN2AURKASYKPDPK1
SCHEMBL18830327 0.81 MAPT (0.36) MAPTSMN1; SMN2SYKRAB9AKDM4E
SCHEMBL19676002 0.80 MAPT (0.54) MAPTSMN1; SMN2AURKASYKPDPK1
SCHEMBL22719010 0.79 MEN1 (0.61) MAPTSMN1; SMN2AURKASYKPDPK1
SCHEMBL15147773 0.79 MAPT (0.53) MAPTSMN1; SMN2AURKASYKPDPK1
SCHEMBL19313055 0.79 SYK (0.72) MAPTSMN1; SMN2AURKASYKGAA
SCHEMBL29535612 0.79 MEN1 (0.61) MAPTSMN1; SMN2AURKASYKPDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2807161-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2017-10-04 — — EP disclosed
EP-2964649-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2017-05-10 — — EP disclosed
Send feedback